MedTrace Logo

Residual Neuromuscular Blockade in Cardiac Surgery Patients

NCT03574337 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-02-16

No results posted yet for this study

Summary

The purpose of this project is to determine if reversal of neuromuscular blockade in cardiac surgery patients expedites time to extubation in fast track patients.

Conditions

  • Residual Neuromuscular Blockade

Interventions

DRUG

Sugammadex

No additional information

DRUG

neostigmine/glycopyrolate

No additional information

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Mary Jarzebowski, MD · Henry Ford Health Systems

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2018-08-30
Completion
2018-08-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03574337 on ClinicalTrials.gov